Apoptotic mechanisms of quercetin in liver cancer: recent trends and advancements

G Sethi, P Rath, A Chauhan, A Ranjan, R Choudhary… - Pharmaceutics, 2023 - mdpi.com
Due to rising incidence rates of liver cancer and worries about the toxicity of current
chemotherapeutic medicines, the hunt for further alternative methods to treat this malignancy …

Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications

Q Li, L Zhou, S Qin, Z Huang, B Li, R Liu… - European Journal of …, 2023 - Elsevier
The success of inhibitor-based therapeutics is largely constrained by the acquisition of
therapeutic resistance, which is partially driven by the undruggable proteome. The …

[HTML][HTML] 3D-printed magnesium-doped wollastonite/nano-hydroxyapatite bioceramic scaffolds with high strength and anti-tumor property

H Shao, Z Jing, P Xia, T Zhang, Z Nian, W Liu, J Zhu… - Materials & Design, 2023 - Elsevier
It is still a major challenge to remove tumor cells and fill bone defects after tumor resection.
Combined with the 3D printing technology, the composite bioceramics scaffolds were …

2-Aminobenzothiazoles in anticancer drug design and discovery

G Huang, T Cierpicki, J Grembecka - Bioorganic chemistry, 2023 - Elsevier
Cancer is one of the major causes of mortality and morbidity worldwide. Substantial
research efforts have been made to develop new chemical entities with improved anticancer …

BCL-G: 20 years of research on a non-typical protein from the BCL-2 family

ML Hartman, M Czyz - Cell Death & Differentiation, 2023 - nature.com
Proteins from the BCL-2 family control cell survival and apoptosis in health and disease, and
regulate apoptosis-unrelated cellular processes. BCL-Gonad (BCL-G, also known as BCL2 …

Nanomedicines for overcoming cancer drug resistance

T Hu, H Gong, J Xu, Y Huang, F Wu, Z He - Pharmaceutics, 2022 - mdpi.com
Clinically, cancer drug resistance to chemotherapy, targeted therapy or immunotherapy
remains the main impediment towards curative cancer therapy, which leads directly to …

Role of YY1 in the regulation of anti-apoptotic gene products in drug-resistant cancer cells

M Jung, I Bui, B Bonavida - Cancers, 2023 - mdpi.com
Simple Summary New treatments that utilize targeted therapeutic agents or invigorations of
the host immune system to destroy cancer cells are not effective against all cancers or …

New Schiff Base–TMB Hybrids: Design, synthesis and antiproliferative investigation as potential anticancer agents

NM Alyamani - Symmetry, 2023 - mdpi.com
The structural symmetry or asymmetry of organic compounds is one of the most fundamental
characteristics. Z-geometrical isomers are promiscuous and kinetically preferred structures …

Optimization of BAX trigger site activator BTSA1 with improved antitumor potency and in vitro ADMET properties

Z Zhang, S Zhao, J Pei, L Hou, S Luan, H Deng… - European Journal of …, 2023 - Elsevier
Direct activation of the pro-apoptotic protein BAX represents a potential therapeutic strategy
to trigger apoptosis in cancer. Herein, structural optimization of the reported BAX trigger site …

Water-soluble copper (II) 5-fluorouracil complexes bearing polypyridyl co-ligands: synthesis, structures and anticancer activity

C Icsel, VT Yilmaz, M Aygun, M Erkisa… - Dalton Transactions, 2023 - pubs.rsc.org
Five newly synthesized copper (II) 5-fluorouracil (5-FU) complexes of polypyridyl co-ligands
with good solubility in water, namely [CuCl (5-FU)(bpy)(DMSO)](1),[Cu (5-FU)(phen) 2](5 …